Affinity Asset Advisors, LLC Rezolute, Inc. Transaction History
Affinity Asset Advisors, LLC
- $596 Million
- Q2 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 2,200,000 shares of RZLT stock, worth $19.4 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
2,200,000
Previous 1,700,000
29.41%
Holding current value
$19.4 Million
Previous $4.93 Million
99.03%
% of portfolio
1.65%
Previous 0.55%
Shares
6 transactions
Others Institutions Holding RZLT
# of Institutions
96Shares Held
59.4MCall Options Held
713KPut Options Held
19K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$124 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$35.5 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.56MShares$31.4 Million0.08% of portfolio
-
Ubs Group Ag3.04MShares$26.8 Million0.0% of portfolio
-
Great Point Partners LLC Greenwich, CT3.03MShares$26.8 Million11.22% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $342M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...